Research April 25, 2022 TecSalud conducts study with cannabidiol to treat COVID after-effects Specialists from TecSalud and the company Cardiol Therapeutics are researching the use of a molecule derived from cannabidiol (CBD) to treat COVID-19 patients.
Research December 22, 2021 TecSalud to carry out study for COVID-19 with cannabis derivative This is the first study approved by COFEPRIS to be carried out in Mexico with a cannabis plant derivative. TecSalud is the first Center approved for the study of medicinal CBD in Mexico.
